image_alt_text
7

Expert in Engineered Cell-Based Cancer Therapies Appointed USC Viterbi BME Chair

Peter Wang | Via University of Southern California | September 16, 2022

Peter Yingxiao Wang, a specialist in CAR T-cell cancer therapies, joins USC in January 2023 as the new chair of the Department of Biomedical Engineering.

Research leader in the field of precision medicine, Professor Peter Yingxiao Wang, will join the USC Viterbi School of Engineering on January 1, 2023, as the new chair of the Department of Biomedical Engineering.

Wang — who has pioneered work on controllable engineered cells to directly target tumors — will also be jointly appointed at the Keck School of Medicine of USC. He will lead two research laboratories to be housed in the USC Michelson Center for Convergent Bioscience on the UPC campus and the USC Norris Comprehensive Cancer Center on the USC Health Sciences Campus… Continue reading.

...